We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$186M
AUM Growth
+$12.3M
Cap. Flow
+$12.3M
Cap. Flow %
6.63%
Top 10 Hldgs %
27.45%
Holding
623
New
80
Increased
200
Reduced
184
Closed
42

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.93%
2 Technology 9.76%
3 Consumer Discretionary 7.16%
4 Healthcare 6.95%
5 Financials 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIPR icon
351
Innovative Industrial Properties
IIPR
$1.54B
$44.6K 0.02%
658
+98
+18% +$11K
BMAR icon
352
Innovator US Equity Buffer ETF March
BMAR
$202M
$43.6K 0.02%
946
SPEU icon
353
State Street SPDR Portfolio Europe ETF
SPEU
$713M
$43.3K 0.02%
+1,092
New +$45.5K
CORT icon
354
Corcept Therapeutics
CORT
$12.1B
$43.2K 0.02%
+865
New +$45.3K
FUMB icon
355
First Trust Ultra Short Duration Municipal ETF
FUMB
$255M
$43.2K 0.02%
2,151
+15
+0.7% +$302
RDDT icon
356
Reddit
RDDT
$30.3B
$43.1K 0.02%
+260
New +$32.1K
NVDX icon
357
T-Rex 2X Long NVIDIA Daily Target ETF
NVDX
$410M
$43.1K 0.02%
2,898
USMV icon
358
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
$42.8K 0.02%
483
+1
+0.2% +$92
GBTC icon
359
Grayscale Bitcoin Trust
GBTC
$11.4B
$42.3K 0.02%
548
-1,762
-76% -$116K
SDY icon
360
State Street SPDR S&P Dividend ETF
SDY
$21.1B
$42.3K 0.02%
322
-165
-34% -$23K
REGN icon
361
Regeneron Pharmaceuticals
REGN
$79.7B
$42.2K 0.02%
59
QQQM icon
362
Invesco NASDAQ 100 ETF
QQQM
$103B
$42K 0.02%
+200
New +$41.6K
PSN icon
363
Parsons
PSN
$4.97B
$42K 0.02%
+464
New +$47.3K
SCHD icon
364
Schwab US Dividend Equity ETF
SCHD
$110B
$41.9K 0.02%
1,538
+8
+0.5% +$227
NSP icon
365
Insperity
NSP
$1.97B
$40.9K 0.02%
541
+2
+0.4% +$162
PHO icon
366
Invesco Water Resources ETF
PHO
$1.93B
$40.7K 0.02%
623
+63
+11% +$4.39K
SPTS icon
367
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$7.31B
$40.6K 0.02%
1,403
MDT icon
368
Medtronic
MDT
$118B
$40.6K 0.02%
506
-4
-0.8% -$346
AGYS icon
369
Agilysys
AGYS
$2.97B
$40.6K 0.02%
+313
New +$38.3K
IGSB icon
370
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$40.5K 0.02%
783
IVE icon
371
iShares S&P 500 Value ETF
IVE
$49B
$40.5K 0.02%
213
IUSG icon
372
iShares Core S&P US Growth ETF
IUSG
$32.7B
$40.4K 0.02%
290
PRIM icon
373
Primoris Services
PRIM
$4.14B
$40K 0.02%
520
CRWD icon
374
CrowdStrike
CRWD
$247B
$39.9K 0.02%
460
CB icon
375
Chubb
CB
$132B
$39.5K 0.02%
145
+8
+6% +$2.27K

Similar funds

Castleview Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Castleview Partners held 623 positions worth $186M, up 7.1% from $173M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Castleview Partners deployed $12.3M of net new capital in Q4 2024, opening 80 new positions and adding to 200 existing holdings. Its largest new stake was ConocoPhillips: 28,165 shares worth $2.82M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 54% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was VanEck CLO ETF, an estimated $594K trimmed.

  • Castleview Partners's largest Q4 2024 buy was ConocoPhillips: 28,165 shares worth $2.82M.
  • Castleview Partners added most to VanEck AA-BB CLO ETF in Q4 2024, an estimated $930K increase.
  • Castleview Partners's biggest Q4 2024 reduction was VanEck CLO ETF, cutting an estimated $594K.
  • Castleview Partners fully exited YieldMax Ultra Option Income Strategy ETF in Q4 2024, selling an estimated $627K.
  • Castleview Partners's ten largest holdings make up 27% of its $186M portfolio in Q4 2024.
  • Castleview Partners opened 80 new positions and closed 42 in Q4 2024.
  • Castleview Partners's portfolio value rose 7.1% quarter-over-quarter to $186M.

Based on Castleview Partners's 13F filing for Q4 2024, filed 21 Jan 2025.